MYRIAD GENETICS INC (MYGN) Goodwill USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Myriad Genetics Inc quarterly Goodwill history and growth rate from 2011 to 2024.
  • Myriad Genetics Inc Goodwill for the quarter ending March 31, 2024 was $287M, a 0.04% decline year-over-year.
Goodwill, Quarterly Data (USD)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $287M -$100K -0.04% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $287M +$600K +0.21% Dec 31, 2023 10-Q 2024-05-08
Q3 2023 $287M +$50.1M +21.2% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $287M +$49.4M +20.8% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $287M +$48.3M +20.2% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $287M +$47.6M +19.9% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $237M -$3.2M -1.34% Sep 30, 2022 10-Q 2022-11-02
Q2 2022 $238M -$2.3M -0.96% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 $239M -$89.5M -27.3% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $239M -$90M -27.3% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $240M -$88.6M -27% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $240M -$87.5M -26.7% Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $328M +$1.2M +0.37% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $329M -$78.9M -19.3% Dec 31, 2020 10-K 2022-02-25
Q3 2020 $328M -$87.8M -21.1% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $328M -$89.6M -21.5% Jun 30, 2020 10-KT 2021-03-16
Q1 2020 $327M -$88.8M -21.4% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $408M -$5.1M -1.23% Dec 31, 2019 10-Q 2020-02-07
Q3 2019 $416M +$2.8M +0.68% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $417M +$98.6M +30.9% Jun 30, 2019 10-KT 2021-03-16
Q1 2019 $416M +$95.7M +29.9% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $413M +$93.8M +29.4% Dec 31, 2018 10-Q 2019-02-06
Q3 2018 $413M +$94.3M +29.6% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $319M +$2.5M +0.79% Jun 30, 2018 10-KT 2021-03-16
Q1 2018 $320M +$5.2M +1.65% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 $319M +$4M +1.27% Dec 31, 2017 10-Q 2018-02-07
Q3 2017 $319M +$6.2M +1.98% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $316M +$121M +61.9% Jun 30, 2017 10-K 2019-08-13
Q1 2017 $315M +$137M +77.1% Mar 31, 2017 10-Q 2017-05-03
Q4 2016 $315M +$138M +78.2% Dec 31, 2016 10-Q 2017-02-08
Q3 2016 $313M +$136M +76.4% Sep 30, 2016 10-Q 2016-11-02
Q2 2016 $195M +$18.1M +10.2% Jun 30, 2016 10-K 2018-08-24
Q1 2016 $178M -$7.33M -3.96% Mar 31, 2016 10-Q 2016-05-04
Q4 2015 $177M +$7.82M +4.62% Dec 31, 2015 10-Q 2016-02-03
Q3 2015 $177M +$8.12M +4.8% Sep 30, 2015 10-Q 2015-11-04
Q2 2015 $177M +$8M +4.73% Jun 30, 2015 10-K 2017-08-09
Q1 2015 $185M +$18.5M +11.1% Mar 31, 2015 10-Q 2015-05-06
Q4 2014 $169M +$112M +198% Dec 31, 2014 10-Q 2015-02-04
Q3 2014 $169M +$112M +198% Sep 30, 2014 10-Q 2014-11-05
Q2 2014 $169M +$112M +197% Jun 30, 2014 10-K 2016-08-10
Q1 2014 $167M +$110M +193% Mar 31, 2014 10-Q 2014-05-07
Q4 2013 $56.9M $0 0% Dec 31, 2013 10-Q 2014-02-05
Q3 2013 $56.9M $0 0% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $56.9M +$50K +0.09% Jun 30, 2013 10-K 2015-08-12
Q1 2013 $56.9M $0 0% Mar 31, 2013 10-Q 2013-05-08
Q4 2012 $56.9M $0 0% Dec 31, 2012 10-Q 2013-02-06
Q3 2012 $56.9M $0 0% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 $56.9M +$799K +1.43% Jun 30, 2012 10-K 2014-08-13
Q1 2012 $56.9M Mar 31, 2012 10-Q 2012-05-02
Q4 2011 $56.9M Dec 31, 2011 10-Q 2012-02-01
Q3 2011 $56.9M Sep 30, 2011 10-Q 2011-11-02
Q2 2011 $56.1M Jun 30, 2011 10-K 2012-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.